Walgreens Boots Alliance (NASDAQ:WBA) PT Lowered to $20.00 at JPMorgan Chase & Co.

Walgreens Boots Alliance (NASDAQ:WBA) had its price objective trimmed by JPMorgan Chase & Co. from $30.00 to $20.00 in a research note released on Monday, Benzinga reports. The firm currently has an overweight rating on the pharmacy operator’s stock.

Other analysts have also recently issued reports about the company. UBS Group dropped their price objective on Walgreens Boots Alliance from $22.00 to $17.00 and set a neutral rating for the company in a report on Monday, June 24th. Bank of America reaffirmed an underperform rating and issued a $11.00 price target (down from $22.00) on shares of Walgreens Boots Alliance in a research note on Friday, June 28th. Raymond James reaffirmed a market perform rating on shares of Walgreens Boots Alliance in a research note on Tuesday, March 26th. Evercore ISI lowered their price target on Walgreens Boots Alliance from $17.00 to $10.00 and set an in-line rating for the company in a research note on Friday, June 28th. Finally, Deutsche Bank Aktiengesellschaft lowered their price target on Walgreens Boots Alliance from $23.00 to $22.00 and set a hold rating for the company in a research note on Wednesday, April 3rd. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, Walgreens Boots Alliance currently has a consensus rating of Hold and a consensus price target of $17.71.

Walgreens Boots Alliance Stock Performance

Shares of NASDAQ:WBA opened at $11.10 on Monday. The stock has a market capitalization of $9.58 billion, a P/E ratio of -1.65, a P/E/G ratio of 0.82 and a beta of 0.72. Walgreens Boots Alliance has a 1-year low of $11.10 and a 1-year high of $31.32. The company has a current ratio of 0.65, a quick ratio of 0.31 and a debt-to-equity ratio of 0.49. The business has a 50-day moving average price of $16.23 and a two-hundred day moving average price of $19.95.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share for the quarter, missing the consensus estimate of $0.68 by ($0.05). The firm had revenue of $36.40 billion for the quarter, compared to the consensus estimate of $35.94 billion. Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The business’s revenue for the quarter was up 2.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.00 earnings per share. Equities analysts predict that Walgreens Boots Alliance will post 2.86 earnings per share for the current year.

Walgreens Boots Alliance Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, June 12th. Stockholders of record on Tuesday, May 21st were issued a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 9.01%. The ex-dividend date was Monday, May 20th. Walgreens Boots Alliance’s payout ratio is presently -14.84%.

Insider Activity

In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari purchased 3,000 shares of the company’s stock in a transaction that occurred on Thursday, April 11th. The shares were acquired at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the purchase, the director now owns 3,000 shares in the company, valued at $54,150. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 17.40% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its stake in shares of Walgreens Boots Alliance by 14.5% in the third quarter. Vanguard Group Inc. now owns 86,675,198 shares of the pharmacy operator’s stock valued at $1,927,656,000 after buying an additional 10,962,030 shares during the period. Capital World Investors grew its position in Walgreens Boots Alliance by 57.5% during the first quarter. Capital World Investors now owns 29,061,021 shares of the pharmacy operator’s stock worth $630,334,000 after buying an additional 10,612,373 shares in the last quarter. Morgan Stanley grew its position in Walgreens Boots Alliance by 15.8% during the third quarter. Morgan Stanley now owns 12,584,371 shares of the pharmacy operator’s stock worth $279,876,000 after buying an additional 1,720,228 shares in the last quarter. Norges Bank acquired a new stake in Walgreens Boots Alliance during the fourth quarter worth approximately $29,816,000. Finally, International Assets Investment Management LLC grew its position in Walgreens Boots Alliance by 1,985.1% during the fourth quarter. International Assets Investment Management LLC now owns 889,546 shares of the pharmacy operator’s stock worth $23,226,000 after buying an additional 846,884 shares in the last quarter. Institutional investors own 58.59% of the company’s stock.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.